TRASTUZUMAB IMBOTOLIMOD

UNII:	LNG8RG3NMF
Type:	INGREDIENT SUBSTANCE
Formula:
Preferred Substance Name:	TRASTUZUMAB IMBOTOLIMOD
GSRS Full Record:	LNG8RG3NMF i

2643926-85-4
BDC-1001
BDC1001
Immunoglobulin G1 [de-450-lysine], anti-(human epidermal growth factor receptor HER2) (human-Mus musculus monoclonal BDC-1001 γ1-chain), disulfide with human-Mus musculus monoclonal BDC-1001 κ-chain, dimer, N6-[33-[4-(4-amino-2-butyl-1H-imidazo[4,5-c]quinolin-8-yl)-1-piperazinyl]-1-oxo-4,7,10,13,16,19,22,25,28,31-decaoxatritriacont-1-yl]-L-lysine
Trastuzumab Imbotolimod
Trastuzumab imbotolimod [WHO-DD]
trastuzumab imbotolimod [INN]

Common Chemistry
i
Inxight Drugs
i
NCI Thesaurus
i

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

TRASTUZUMAB IMBOTOLIMOD

Synonyms and Mappings

Resources